About Myeloma: A Shareable Guide for Patients, Family and Friends


Do you love Patient Power? Want other cancer patients to feel empowered too? Help spread the word about Patient Power by sharing our downloadable guide. Simply save the guide to your computer, then print out a few copies and pass them out to fellow patients and doctors during your next appointment. You can also share it via email or social media. This way, people who don't know about Patient Power are now in the loop and can become a part of the Patient Power community! You, loyal Patient Power community member, are our greatest advocate, and we appreciate you! Thanks for helping us share our free, educational resources with the world!



  • Multiple myeloma is a cancer formed by malignant plasma cells in the blood. 
  • Plasma cells are typically found in the bone marrow where blood cells are created and are an important part of the immune system. When plasma cells become cancerous and grow out of control, they can produce a tumor called a plasmacytoma. If someone has more than one plasmacytoma, they have multiple myeloma. 
  • There are subtypes of myeloma, and the course of the disease can vary greatly by patient. 
  • There are now several effective medicines, used alone or in combination, that treat myeloma, and people are living longer with a better quality of life than ever before. Treatment research is accelerating, and there is growing possibility that new medicines can activate the immune system to more successfully combat this disease.
  • It is important to inquire about clinical trials to potentially access promising breakthrough therapies.


Myeloma Support

A diagnosis of multiple myeloma can be overwhelming for the entire family. Open discussion between family members, health professionals and patients can help ensure the best care. There are many resources available to find a wide range of information on the management and treatment of multiple myeloma. We encourage you to join our community and to check out our brief videos to find the most up-to-date information from leading experts about support, treatments, clinical trials, communication, financial issues and much more.

Join the Community

Myeloma Clinical Trials



About Myeloma: A Shareable Guide for Patients, Family and Friends

Email this program

Get Link

Myeloma Videos and Transcripts

What Is Multiple Myeloma? An Expert Explains

We know multiple myeloma is a blood cancer, but what it is it exactly? Dr. Robert Orlowski defines myeloma, describes the early symptoms, and discusses the diagnostic procedures.


Smoldering Myeloma and MGUS: Why Watch and Wait?

Dr. Robert Orlowski from MD Anderson Cancer Center and Dr. Paul Richardson from Dana-Farber Cancer Institute, define the terms MGUS and smoldering myeloma as well as the reasoning behind the watch and wait period.


When Should I Consider a Clinical Trial for Multiple Myeloma Treatment?

Hear why Dr. Robert Orlowski thinks patients should consider clinical trials at every step in their multiple myeloma treatment journey.


Can I Avoid or Postpone Stem Cell Transplant for Multiple Myeloma?

Dr. Orlowski discusses whether it makes sense for some multiple myeloma patients to avoid stem cell transplant in light of recent drug developments.


Understanding M Protein Level and MRD Testing in Myeloma

What is a good M protein level range for myeloma patients? When is MRD testing recommended? Watch now to hear expert Dr. Elisabet Manasanch explain.


Is Maintenance Therapy Necessary for MRD-Negative Myeloma Patients?

If a myeloma patient is declared MRD-negative, do they still need maintenance therapy indefinitely? Tune in as Dr. Elisabet Manasanch gives expert advice and explains current research on patients with MRD-negative status.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on June 13, 2019